| Year |
Citation |
Score |
| 2024 |
Xiong LY, Wood Alexander M, Wong YY, Wu CY, Ruthirakuhan M, Edwards JD, Lanctôt KL, Black SE, Rabin JS, Cogo-Moreira H, Swardfager W. Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes. Molecular Psychiatry. PMID 39103532 DOI: 10.1038/s41380-024-02685-4 |
0.53 |
|
| 2024 |
Anita NZ, Herrmann N, Ryoo SW, Major-Orfao C, Lin WZ, Kwan F, Noor S, Rabin JS, Marzolini S, Nestor S, Ruthirakuhan MT, MacIntosh BJ, Goubran M, Yang P, Cogo-Moreira H, et al. Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes. Journal of Diabetes and Its Complications. 38: 108826. PMID 39059187 DOI: 10.1016/j.jdiacomp.2024.108826 |
0.542 |
|
| 2024 |
Xiong LY, Wood Alexander M, Cogo-Moreira H, Wu CY, Eid M, Herrmann N, Gallagher D, Edwards JD, Lanctôt KL, Marzolini S, Bennett DA, Rabin JS, Swardfager W. Longitudinal relationships between depressive symptoms, functional impairment, and physical activity in later late life. Geroscience. PMID 39023667 DOI: 10.1007/s11357-024-01282-1 |
0.52 |
|
| 2024 |
Ruthirakuhan M, Swardfager W, Xiong L, MacIntosh BJ, Rabin JS, Lanctôt KL, Ottoy J, Ramirez J, Keith J, Black SE. Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38425134 DOI: 10.1002/alz.13717 |
0.528 |
|
| 2023 |
Song BX, Azhar L, Koo GKY, Marzolini S, Gallagher D, Swardfager W, Chen C, Ba J, Herrmann N, Lanctôt KL. The effect of exercise on blood concentrations of angiogenesis markers in older adults: A systematic review and meta-analysis. Neurobiology of Aging. 135: 15-25. PMID 38147807 DOI: 10.1016/j.neurobiolaging.2023.12.004 |
0.492 |
|
| 2023 |
Wu CY, Wang C, Saskin R, Shah BR, Kapral MK, Lanctôt KL, Herrmann N, Cogo-Moreira H, MacIntosh BJ, Edwards JD, Swardfager W. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes. Journal of Internal Medicine. PMID 37747779 DOI: 10.1111/joim.13723 |
0.537 |
|
| 2023 |
Anita NZ, Kwan F, Ryoo SW, Major-Orfao C, Lin WZ, Noor S, Lanctôt KL, Herrmann N, Oh PI, Shah BR, Gilbert J, Assal A, Halperin IJ, Taha AY, Swardfager W. Cytochrome p450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes. Journal of Lipid Research. 100395. PMID 37245563 DOI: 10.1016/j.jlr.2023.100395 |
0.51 |
|
| 2023 |
Wu CY, Iskander C, Wang C, Xiong LY, Shah BR, Edwards JD, Kapral MK, Herrmann N, Lanctôt KL, Masellis M, Swartz RH, Cogo-Moreira H, MacIntosh BJ, Rabin JS, Black SE, et al. Association of sulfonylureas with the risk of dementia: A population-based cohort study. Journal of the American Geriatrics Society. PMID 37218376 DOI: 10.1111/jgs.18397 |
0.531 |
|
| 2023 |
Cogo-Moreira H, Krance SH, Wu CY, Lanctôt KL, Herrmann N, Black SE, MacIntosh BJ, Rabin JS, Eid M, Swardfager W. State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 9: e12376. PMID 36994227 DOI: 10.1002/trc2.12376 |
0.562 |
|
| 2023 |
Song BX, Azhar L, Koo GKY, Marzolini S, Gallagher D, Swardfager W, Chen C, Ba J, Herrmann N, Lanctôt K. The effect of exercise on blood concentrations of angiogenesis markers in older adults: a systematic review and meta-analysis. Research Square. PMID 36711740 DOI: 10.21203/rs.3.rs-2468576/v1 |
0.493 |
|
| 2022 |
Yu D, Liang N, Zebarth J, Shen Q, Ozzoude M, Goubran M, Rabin JS, Ramirez J, Scott CJM, Gao F, Bartha R, Symons S, Haddad SMH, Berezuk C, Tan B, et al. Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke. Journal of the American Heart Association. 12: e026901. PMID 36583428 DOI: 10.1161/JAHA.122.026901 |
0.481 |
|
| 2022 |
Ruthirakuhan M, Cogo-Moreira H, Swardfager W, Herrmann N, Lanctot KL, Black SE. Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach. Journal of the American Heart Association. 12: e025724. PMID 36565204 DOI: 10.1161/JAHA.122.025724 |
0.54 |
|
| 2022 |
Wu CY, Iskander C, Wang C, Xiong LY, Shah BR, Edwards JD, Kapral MK, Herrmann N, Lanctôt KL, Masellis M, Swartz RH, Cogo-Moreira H, MacIntosh BJ, Rabin JS, Black SE, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors with Time to Dementia: A Population-Based Cohort Study. Diabetes Care. PMID 36508692 DOI: 10.2337/dc22-1705 |
0.51 |
|
| 2022 |
Bawa KK, Ba J, Kiss A, Wang R, Feng V, Swardfager W, Andreazza A, Gallagher D, Marotta G, Herrmann N, Lanctôt KL. Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 35938248 DOI: 10.3233/JAD-220274 |
0.536 |
|
| 2022 |
Krance SH, Wu CY, Chan ACY, Kwong S, Song BX, Xiong LY, Ouk M, Chen MH, Zhang J, Yung A, Stanley M, Herrmann N, Lanctôt KL, Swardfager W. Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease : Jad. PMID 35754279 DOI: 10.3233/JAD-220360 |
0.532 |
|
| 2022 |
Wu CY, Xiong LY, Ouk M, Rabin JS, Herrmann N, Lanctôt KL, Kapral MK, Law M, Cogo-Moreira H, Edwards JD, Swardfager W. Gastric acid suppressants and cognitive decline in people with or without cognitive impairment. Alzheimer's & Dementia (New York, N. Y.). 8: e12243. PMID 35169610 DOI: 10.1002/trc2.12243 |
0.53 |
|
| 2021 |
Anita NZ, Zebarth J, Chan B, Wu CY, Syed T, Shahrul D, Nguyen MM, Pakosh M, Herrmann N, Lanctôt KL, Swardfager W. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; A systematic review and meta-analysis. Brain, Behavior, and Immunity. PMID 34808290 DOI: 10.1016/j.bbi.2021.11.005 |
0.552 |
|
| 2021 |
Ghosh I, Liu CS, Swardfager W, Lanctôt KL, Anderson ND. The potential roles of excitatory-inhibitory imbalances and the repressor element-1 silencing transcription factor in aging and aging-associated diseases. Molecular and Cellular Neurosciences. 117: 103683. PMID 34775008 DOI: 10.1016/j.mcn.2021.103683 |
0.48 |
|
| 2021 |
Teselink J, Bawa KK, Koo GK, Sankhe K, Liu CS, Rapoport M, Oh P, Marzolini S, Gallagher D, Swardfager W, Herrmann N, Lanctôt KL. Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer's disease and Mild Cognitive Impairment: A meta-analysis and systematic review. Ageing Research Reviews. 101499. PMID 34700007 DOI: 10.1016/j.arr.2021.101499 |
0.556 |
|
| 2021 |
Nguyen MM, Perlman G, Kim N, Wu CY, Daher V, Zhou A, Mathers EH, Anita NZ, Lanctôt KL, Herrmann N, Pakosh M, Swardfager W. Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers. Psychoneuroendocrinology. 134: 105448. PMID 34687965 DOI: 10.1016/j.psyneuen.2021.105448 |
0.526 |
|
| 2021 |
Xiong LY, Ouk M, Wu CY, Rabin JS, Lanctôt KL, Herrmann N, Black SE, Edwards JD, Swardfager W. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia. Alzheimer's Research & Therapy. 13: 147. PMID 34479635 DOI: 10.1186/s13195-021-00892-7 |
0.553 |
|
| 2021 |
MacIntosh BJ, Cohen E, Colby-Milley J, Fang J, Zhou L, Ouk M, Wu CY, Shah BR, Lanctôt K, Herrmann N, Linkewich E, Law M, Black SE, Swartz RH, Kapral MK, et al. Diabetes Mellitus Is Associated With Poor In-Hospital and Long-Term Outcomes in Young and Midlife Stroke Survivors. Journal of the American Heart Association. e019991. PMID 34219470 DOI: 10.1161/JAHA.120.019991 |
0.484 |
|
| 2021 |
Ouk M, Wu CY, Rabin JS, Jackson A, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Alzheimer's Research & Therapy. 13: 43. PMID 33573702 DOI: 10.1186/s13195-021-00778-8 |
0.518 |
|
| 2021 |
Anita NZ, Forkan N, Kamal R, Nguyen MM, Yu D, Major-Orfao C, Wong SK, Lanctôt KL, Herrmann N, Oh PI, Shah BR, Gilbert J, Assal A, Halperin IJ, Pedersen TL, et al. Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes. Psychoneuroendocrinology. 126: 105149. PMID 33503568 DOI: 10.1016/j.psyneuen.2021.105149 |
0.515 |
|
| 2020 |
Ouk M, Wu CY, Rabin JS, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Neurobiology of Aging. 100: 22-31. PMID 33461049 DOI: 10.1016/j.neurobiolaging.2020.12.011 |
0.53 |
|
| 2020 |
Ouk M, Wu CY, Colby-Milley J, Fang J, Zhou L, Shah BR, Herrmann N, Lanctôt KL, Linkewich E, Law M, Swartz RH, Kapral MK, Black SE, MacIntosh BJ, Edwards JD, et al. Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke. Stroke. 51: 3531-3540. PMID 33226916 DOI: 10.1161/STROKEAHA.120.031068 |
0.515 |
|
| 2020 |
Nguyen MM, Anita NZ, Darwish L, Major-Orfao C, Colby-Milley J, Wong SK, Sugamori KS, Lanctôt KL, Herrmann N, Oh PI, Yang P, Shah BR, Gilbert J, Assal A, Halperin IJ, et al. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes. Psychoneuroendocrinology. 122: 104878. PMID 33038647 DOI: 10.1016/j.psyneuen.2020.104878 |
0.501 |
|
| 2020 |
Wu CY, Ouk M, Wong YY, Anita NZ, Edwards JD, Yang P, Shah BR, Herrmann N, Lanctôt KL, Kapral MK, MacIntosh BJ, Rabin JS, Black SE, Swardfager W. Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32803865 DOI: 10.1002/Alz.12161 |
0.579 |
|
| 2020 |
Wu CY, Bawa KK, Ouk M, Leung N, Yu D, Lanctôt KL, Herrmann N, Pakosh M, Swardfager W. Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid. Ageing Research Reviews. 101130. PMID 32712109 DOI: 10.1016/J.Arr.2020.101130 |
0.593 |
|
| 2020 |
Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, et al. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 32565008 DOI: 10.1016/J.Jagp.2020.05.020 |
0.318 |
|
| 2020 |
Isaacs-Trepanier C, Saleem M, Herrmann N, Swardfager W, Oh PI, Goldstein BI, Mitchell J, Sugamori KS, Lanctôt KL. Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 32538839 DOI: 10.3233/Jad-200058 |
0.591 |
|
| 2020 |
van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 32461027 DOI: 10.1016/J.Jagp.2020.04.026 |
0.331 |
|
| 2020 |
Cogo-Moreira H, Krance SH, Black SE, Herrmann N, Lanctôt KL, MacIntosh BJ, Eid M, Swardfager W. Questioning the Meaning of a Change on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time. Assessment. 1073191120915273. PMID 32406251 DOI: 10.1177/1073191120915273 |
0.58 |
|
| 2020 |
Bawa KK, Krance SH, Herrmann N, Cogo-Moreira H, Ouk M, Yu D, Wu CY, Black SE, Lanctôt KL, Swardfager W. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease. Journal of Neuroinflammation. 17: 84. PMID 32171317 DOI: 10.1186/S12974-020-01750-3 |
0.601 |
|
| 2020 |
Wong SK, Nguyen MM, Major-Orfao C, Lanctôt KL, Herrmann N, Oh P, Shah BR, Gilbert J, Assal A, Halperin I, Yang P, Pedersen T, Taha A, Swardfager W. 36-LB: Linoleic Acid Derived Oxylipins, Memory, and Microvascular Retinal Complications in Patients with Type 2 Diabetes Mellitus Diabetes. 69. DOI: 10.2337/Db20-36-Lb |
0.523 |
|
| 2020 |
Liu C, Gallagher D, Rapoport M, Charles J, Papneja P, Marzolini S, Oh P, Kiss A, Rajji T, Andreazza A, Herrmann N, Lanctot K. Evaluating The Cognitive Effects Of Exercise Priming And Transcranial Direct Current Stimulation In Mild Cognitive Impairment And Mild Alzheimer'S Disease: The Express Study American Journal of Geriatric Psychiatry. 28. DOI: 10.1016/J.Jagp.2020.01.101 |
0.35 |
|
| 2020 |
Mah L, Lanctôt K, Kumar S, Fischer C. Novel Neurostimulation Approaches: Focus On Neuropsychiatric Symptoms American Journal of Geriatric Psychiatry. 28. DOI: 10.1016/J.Jagp.2020.01.024 |
0.331 |
|
| 2020 |
Nguyen M, Darwish L, Major-Orfao C, Colby-Milley J, Wong SK, Sugamori KS, Lanctôt KL, Herrmann N, Oh PI, Yang P, Shah BR, Gilbert J, Assal A, Halperin IJ, Mitchell J, et al. Relationships Between Serum Osteocalcin, Brain Derived Neurotrophic Factor and Subjective Stress in People With and Without Depression and Type 2 Diabetes Mellitus Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1115 |
0.548 |
|
| 2019 |
Fischer CE, Ismail Z, Youakim JM, Creese B, Kumar S, Nuñez N, Darby RR, Di Vita A, D'Antonio F, de Lena C, McGeown WJ, Ramit R, Rasmussen J, Bell J, Wang H, et al. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. Journal of Alzheimer's Disease : Jad. PMID 31884469 DOI: 10.3233/Jad-190828 |
0.354 |
|
| 2019 |
Liu CS, Herrmann N, Gallagher D, Rajji TK, Kiss A, Vieira D, Lanctôt KL. A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease. The Journal of Ect. PMID 31790015 DOI: 10.1097/Yct.0000000000000639 |
0.347 |
|
| 2019 |
Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL. Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation. Journal of Geriatric Psychiatry and Neurology. 891988719874118. PMID 31547752 DOI: 10.1177/0891988719874118 |
0.302 |
|
| 2019 |
Kapoor A, Si K, Yu AYX, Lanctot KL, Herrmann N, Murray BJ, Swartz RH. Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic Attack. Stroke. STROKEAHA119025464. PMID 31405330 DOI: 10.1161/Strokeaha.119.025464 |
0.312 |
|
| 2019 |
Ruthirakuhan MT, Herrmann N, Gallagher D, Andreazza AC, Kiss A, Verhoeff NPLG, Black SE, Lanctôt KL. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial. Contemporary Clinical Trials Communications. 15: 100385. PMID 31338476 DOI: 10.1016/J.Conctc.2019.100385 |
0.354 |
|
| 2019 |
Ruthirakuhan M, Herrmann N, C Andreazza A, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL. 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone. Journal of Alzheimer's Disease : Jad. PMID 31322567 DOI: 10.3233/Jad-190202 |
0.34 |
|
| 2019 |
Kapoor A, Scott C, Lanctot KL, Herrmann N, Murray BJ, Thorpe KE, Lien K, Sicard M, Swartz RH. Symptoms of depression and cognitive impairment in young adults after stroke/transient ischemic attack. Psychiatry Research. PMID 31272664 DOI: 10.1016/J.Psychres.2019.06.022 |
0.325 |
|
| 2019 |
Khan MM, Lanctôt KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, Gandell D, Brenkel MC, Hazan EL, Docteur NG, Herrmann N. The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clinical Interventions in Aging. 14: 841-848. PMID 31190770 DOI: 10.2147/Cia.S201615 |
0.359 |
|
| 2019 |
Mohammad D, Herrmann N, Saleem M, Swartz RH, Oh PI, Bradley J, Chan P, Ellis C, Lanctôt KL. Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation. Bmc Geriatrics. 19: 163. PMID 31185923 DOI: 10.1186/S12877-019-1177-0 |
0.336 |
|
| 2019 |
Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctôt KL. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31182351 DOI: 10.1016/J.Jagp.2019.05.002 |
0.349 |
|
| 2019 |
Eakin KA, Saleem M, Herrmann N, Cogo-Moreira H, Mielke MM, Oh PI, Haughey NJ, Venkata SLV, Lanctôt KL, Swardfager W. Plasma Sphingolipids Mediate a Relationship Between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise. Journal of Alzheimer's Disease : Jad. PMID 31006687 DOI: 10.3233/Jad-181203 |
0.582 |
|
| 2019 |
Ruthirakuhan M, Herrmann N, Vieira D, Gallagher D, Lanctôt KL. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30910421 DOI: 10.1016/J.Jagp.2019.02.003 |
0.416 |
|
| 2019 |
Darwish L, Nguyen MM, Saleem M, Eakin KA, Herrmann N, Sugamori KS, Oh PI, Yang P, Mitchell J, Lanctôt KL, Swardfager W. Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease. Journal of Diabetes and Its Complications. PMID 30799280 DOI: 10.1016/J.Jdiacomp.2019.01.003 |
0.557 |
|
| 2019 |
Ruthirakuhan M, Lanctôt KL, Vieira D, Herrmann N. Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis. The Journal of Clinical Psychiatry. 80. PMID 30753761 DOI: 10.4088/Jcp.18R12617 |
0.35 |
|
| 2019 |
Yu D, Hennebelle M, Ramirez J, Chan PC, Taha A, Pettersen JA, Herrmann N, Lanctot KL, Swartz RH, Masellis M, Sahlas DJ, Black SE, Swardfager W. P3-252: SERUM OXYLIPINS INDICATE VASCULAR COGNITIVE IMPAIRMENT IN ALZHEIMER'S DISEASE WITH COMORBID CEREBROVASCULAR DISEASE: A PRELIMINARY REPORT Alzheimer's & Dementia. 15: P1032-P1033. DOI: 10.1016/J.Jalz.2019.06.3283 |
0.612 |
|
| 2019 |
Lanctot KL, Docteur NG, Isaacs-Trepanier C, Gallagher D, Black SE, Ramirez J, Oh PI, Kiss A, Swardfager W, Herrmann N. P1-066: DESIGNING A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL GROUP STUDY ON THE EFFICACY AND SAFETY OF N-ACETYLCYSTEINE (NAC) IN PATIENTS WITH MILD VASCULAR COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 15: P258-P258. DOI: 10.1016/J.Jalz.2019.06.091 |
0.571 |
|
| 2019 |
Fischer CE, Lanctot K, Mah L. PREVALENCE OF NEUROPSYCHIATRIC SYMPTOMS ACROSS THE COGNITIVE SPECTRUM AND THEIR IMPACT ON FUTURE COGNITIVE DECLINE The American Journal of Geriatric Psychiatry. 27: S14. DOI: 10.1016/J.Jagp.2019.01.153 |
0.393 |
|
| 2019 |
Thiyagarajah MT, Herrmann N, Ruthirakuhan M, Li A, Lanctôt KL. Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease Current Behavioral Neuroscience Reports. 6: 72-87. DOI: 10.1007/S40473-019-00181-6 |
0.309 |
|
| 2018 |
Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30555031 DOI: 10.1016/J.Jalz.2018.09.009 |
0.313 |
|
| 2018 |
Gallagher D, Kiss A, Lanctot KL, Herrmann N. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. The Journal of Clinical Psychiatry. 80. PMID 30549490 DOI: 10.4088/Jcp.18M12331 |
0.369 |
|
| 2018 |
Mohammad D, Ellis C, Rau A, Rosenberg PB, Mintzer J, Ruthirakuhan M, Herrmann N, Lanctôt KL. Psychometric Properties of Apathy Scales in Dementia: A Systematic Review. Journal of Alzheimer's Disease : Jad. PMID 30400094 DOI: 10.3233/Jad-180485 |
0.311 |
|
| 2018 |
Saleem M, Herrmann N, Dinoff A, Mazereeuw G, Oh PI, Goldstein BI, Kiss A, Shammi P, Lanctôt KL. Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation. Psychosomatic Medicine. PMID 30383709 DOI: 10.1097/Psy.0000000000000651 |
0.361 |
|
| 2018 |
Rosen M, Chan P, Saleem M, Herrmann N, Adibfar A, Andreazza A, Oh PI, Lanctôt KL. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients. Psychiatry Research. 270: 219-224. PMID 30267986 DOI: 10.1016/J.Psychres.2018.09.046 |
0.335 |
|
| 2018 |
Dinoff A, Herrmann N, Swardfager W, Gallagher D, Lanctôt KL. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis. Journal of Psychiatric Research. 105: 123-131. PMID 30219561 DOI: 10.1016/J.Jpsychires.2018.08.021 |
0.563 |
|
| 2018 |
Chan P, Saleem M, Herrmann N, Mielke MM, Haughey NJ, Oh PI, Kiss A, Lanctôt KL. Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study. Journal of Alzheimer's Disease : Jad. PMID 30010121 DOI: 10.3233/Jad-180030 |
0.333 |
|
| 2018 |
Chau SA, Herrmann N, Chung J, Eizenman M, Lanctôt KL. Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot Study. Canadian Geriatrics Journal : Cgj. 21: 139-142. PMID 29977428 DOI: 10.5770/Cgj.21.291 |
0.306 |
|
| 2018 |
Gallagher D, Kiss A, Lanctot K, Herrmann N. Depression and Risk of Alzheimer's Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 29960668 DOI: 10.1016/J.Jagp.2018.05.002 |
0.338 |
|
| 2018 |
Ruthirakuhan M, Lanctôt KL, Di Scipio M, Ahmed M, Herrmann N. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29940162 DOI: 10.1016/J.Jalz.2018.04.013 |
0.35 |
|
| 2018 |
Fishman KN, Ashbaugh AR, Lanctôt KL, Cayley ML, Herrmann N, Murray BJ, Sicard M, Lien K, Sahlas DJ, Swartz RH. The Role of Apathy and Depression on Verbal Learning and Memory Performance After Stroke. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 29788381 DOI: 10.1093/Arclin/Acy044 |
0.318 |
|
| 2018 |
Chan P, Suridjan I, Mohammad D, Herrmann N, Mazereeuw G, Hillyer LM, Ma DWL, Oh PI, Lanctôt KL. Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease. Journal of the American Heart Association. 7. PMID 29730646 DOI: 10.1161/Jaha.117.008278 |
0.343 |
|
| 2018 |
Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Pharmacological interventions for apathy in Alzheimer's disease. The Cochrane Database of Systematic Reviews. 5: CD012197. PMID 29727467 DOI: 10.1002/14651858.Cd012197.Pub2 |
0.34 |
|
| 2018 |
Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Scott CJM, Holmes MF, Sahlas DJ, Kiss A, Oh PI, et al. The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy. Neurology. PMID 29374101 DOI: 10.1212/Wnl.0000000000004983 |
0.572 |
|
| 2018 |
Middleton LE, Black SE, Herrmann N, Oh PI, Regan K, Lanctot KL. Centre- versus home-based exercise among people with mci and mild dementia: study protocol for a randomized parallel-group trial. Bmc Geriatrics. 18: 27. PMID 29370756 DOI: 10.1186/S12877-017-0684-0 |
0.324 |
|
| 2018 |
Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 19: 46. PMID 29347996 DOI: 10.1186/S13063-017-2406-5 |
0.368 |
|
| 2018 |
Graff-Guerrero A, Fischer C, Lanctôt KL, Mah L. Understanding the Link between Neuropsychiatric Symptoms and Cognitive Decline: Insights From Neuroimaging The American Journal of Geriatric Psychiatry. 26: S37. DOI: 10.1016/J.Jagp.2018.01.060 |
0.317 |
|
| 2017 |
Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, Haughey NJ, Lanctôt KL. Plasma sphingolipids and depressive symptoms in coronary artery disease. Brain and Behavior. 7: e00836. PMID 29201542 DOI: 10.1002/Brb3.836 |
0.335 |
|
| 2017 |
Sun M, Lanctot K, Herrmann N, Gallagher D. Exercise for Cognitive Symptoms in Depression: A Systematic Review of Interventional Studies. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717738493. PMID 29186973 DOI: 10.1177/0706743717738493 |
0.34 |
|
| 2017 |
Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, Osorio RS, Rosenberg PB, Satlin A, Steffens D, Tariot P, et al. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimer's & Dementia (New York, N. Y.). 3: 440-449. PMID 29067350 DOI: 10.1016/J.Trci.2017.07.001 |
0.37 |
|
| 2017 |
Liu CS, Rau A, Gallagher D, Rajji TK, Lanctôt KL, Herrmann N. Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer's disease. Neurodegenerative Disease Management. PMID 29043928 DOI: 10.2217/Nmt-2017-0021 |
0.375 |
|
| 2017 |
Chee JN, Rapoport MJ, Molnar F, Herrmann N, O'Neill D, Marottoli R, Mitchell S, Tant M, Dow J, Ayotte D, Lanctôt KL, McFadden R, Taylor JP, Donaghy PC, Olsen K, et al. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 28917504 DOI: 10.1016/J.Jagp.2017.05.007 |
0.339 |
|
| 2017 |
Fishman KN, Ashbaugh AR, Lanctôt KL, Cayley ML, Herrmann N, Murray BJ, Sicard M, Lien K, Sahlas DJ, Swartz RH. Apathy, not depressive symptoms, as a predictor of semantic and phonemic fluency task performance in stroke and transient ischemic attack. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 28911268 DOI: 10.1080/13803395.2017.1371282 |
0.329 |
|
| 2017 |
Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, Carvalho AF, Herrmann N. Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28794151 DOI: 10.1136/Jnnp-2017-316201 |
0.348 |
|
| 2017 |
Swardfager W, Yu D, Scola G, Cogo-Moreira H, Chan P, Zou Y, Herrmann N, Lanctôt KL, Ramirez J, Gao F, Masellis M, Swartz RH, Sahlas DJ, Chan PC, Ojeda-Lopez C, et al. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease. Neurobiology of Aging. PMID 28756941 DOI: 10.1016/J.Neurobiolaging.2017.06.029 |
0.584 |
|
| 2017 |
Edwards JD, Ramirez J, Callahan BL, Tobe SW, Oh P, Berezuk C, Lanctôt K, Swardfager W, Nestor S, Kiss A, Strother S, Black SE. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study. Journal of Alzheimer's Disease : Jad. PMID 28731439 DOI: 10.3233/Jad-170238 |
0.599 |
|
| 2017 |
Dinoff A, Herrmann N, Swardfager W, Lanctôt KL. The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor (BDNF) in healthy adults: A meta-analysis. The European Journal of Neuroscience. PMID 28493624 DOI: 10.1111/Ejn.13603 |
0.554 |
|
| 2017 |
Santiago C, Herrmann N, Swardfager W, Saleem M, Oh PI, Black SE, Bradley J, Lanctôt KL. Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation. International Journal of Geriatric Psychiatry. PMID 28474775 DOI: 10.1002/Gps.4729 |
0.581 |
|
| 2017 |
Swardfager W, Yu D, Ramirez J, Cogo-Moreira H, Szilagyi G, Holmes MF, Scott CJ, Scola G, Chan PC, Chen J, Chan P, Sahlas DJ, Herrmann N, Lanctôt KL, Andreazza AC, et al. Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report. Alzheimer's & Dementia (Amsterdam, Netherlands). 7: 56-60. PMID 28275700 DOI: 10.1016/J.Dadm.2016.12.011 |
0.581 |
|
| 2017 |
Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctôt KL, Miller DS, Mortby ME, Onyike CU, Rosenberg PB, et al. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. Journal of Alzheimer's Disease : Jad. PMID 28059789 DOI: 10.3233/Jad-160979 |
0.347 |
|
| 2017 |
Lanctot KL, Scherer R, Li A, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey AI, Burke WJ, Mintzer JE. MEASURING APATHY IN ALZHEIMER'S DISEASE IN THE APATHY IN DEMENTIA METHYLPHENIDATE TRIAL 2 (ADMET 2): A COMPARISON OF INSTRUMENTS Alzheimer's & Dementia. 13: P184. DOI: 10.1016/J.Jalz.2017.07.038 |
0.341 |
|
| 2017 |
Yu D, Ramirez J, Cogo-Moreira H, Scola G, Chan PC, Chan P, Sahlas DJ, Herrmann N, Lanctot KL, Andreazza AC, Masellis M, Pettersen JA, Black SE, Swardfager W. Inflammation Mediates The Impact Of Small-Vessel Disease On Cognition In Alzheimer'S Disease: Evidence From A Multimodal Stratified Cohort Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.871 |
0.612 |
|
| 2017 |
Herrmann N, Saleem M, Dinoff A, Mazereeuw G, Oh PI, Goldstein B, Shammi P, Lanctot KL. [P4-195]: ENDOTHELIAL FUNCTION IS ASSOCIATED WITH COGNITION IN CORONARY ARTERY DISEASE Alzheimer's & Dementia. 13: P1340-P1340. DOI: 10.1016/J.Jalz.2017.06.2062 |
0.337 |
|
| 2017 |
Ruthirakuhan M, Herrmann N, Abraham EH, Sherman C, Verhoeff NPL, Kiss A, Black SE, Andreazza AC, Lanctot KL. [P4-003]: A RANDOMIZED, PLACEBO-CONTROLLED, CROSS-OVER TRIAL INVESTIGATING NABILONE AS A TREATMENT FOR AGITATION IN PATIENTS WITH MODERATE-TO-SEVERE ALZHEIMER'S DISEASE: BLINDED, INTERIM SAFETY RESULTS Alzheimer's & Dementia. 13: P1254-P1254. DOI: 10.1016/J.Jalz.2017.06.1867 |
0.322 |
|
| 2017 |
Saleem M, Herrmann N, Dinoff A, Mielke MM, Oh PI, Shammi P, Cao X, Ratnam Bandaru VV, Haughey NJ, Lanctot KL, Li A. [P3-239]: A LIPIDOMICS APPROACH TO ASSESS PLASMA SPHINGOLIPIDS AS PREDICTORS OF VERBAL MEMORY PERFORMANCE IN CORONARY ARTERY DISEASE PATIENTS UNDERTAKING CARDIAC REHABILITATION: A C18:0 SIGNATURE FOR COGNITIVE RESPONSE TO EXERCISE Alzheimer's & Dementia. 13: P1031-P1031. DOI: 10.1016/J.Jalz.2017.06.1452 |
0.335 |
|
| 2017 |
Dinoff A, Saleem M, Herrmann N, Haughey NJ, Oh PI, Mielke MM, Lanctot KL. [P3-210]: PLASMA SPHINGOLIPID RATIOS AND VERBAL MEMORY PERFORMANCE IN A CORONARY ARTERY DISEASE POPULATION AT RISK FOR VASCULAR COGNITIVE IMPAIRMENT (VCI) AND ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1016-P1017. DOI: 10.1016/J.Jalz.2017.06.1423 |
0.373 |
|
| 2017 |
Dinoff A, Herrmann N, Swardfager W, Liu C, Sherman C, Chan S, Lanctôt K. 996. The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-derived Neurotrophic Factor (BDNF): A Meta-analysis Biological Psychiatry. 81: S403. DOI: 10.1016/j.biopsych.2017.02.723 |
0.468 |
|
| 2016 |
Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL. Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease. Neuropsychiatric Disease and Treatment. 12: 2913-2920. PMID 27877045 DOI: 10.2147/Ndt.S115505 |
0.345 |
|
| 2016 |
Chau SA, Herrmann N, Sherman C, Chung J, Eizenman M, Kiss A, Lanctôt KL. Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients. Journal of Alzheimer's Disease : Jad. PMID 27834775 DOI: 10.3233/Jad-160641 |
0.341 |
|
| 2016 |
Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt K. Beyond Immunotherapy: New Approaches for Disease Modifying Treatments for Early Alzheimer's disease. Expert Opinion On Pharmacotherapy. PMID 27825018 DOI: 10.1080/14656566.2016.1258060 |
0.337 |
|
| 2016 |
Mazereeuw G, Herrmann N, Andreazza AC, Scola G, Wl Ma D, I Oh P, Lanctôt KL. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. Brain, Behavior, and Immunity. PMID 27742581 DOI: 10.1016/J.Bbi.2016.10.005 |
0.324 |
|
| 2016 |
Dinoff A, Herrmann N, Swardfager W, Liu CS, Sherman C, Chan S, Lanctôt KL. The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis. Plos One. 11: e0163037. PMID 27658238 DOI: 10.1016/J.Biopsych.2017.02.723 |
0.544 |
|
| 2016 |
Köhler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanctôt KL, Carvalho AF. The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer's disease. Current Pharmaceutical Design. PMID 27604604 DOI: 10.2174/1381612822666160907093807 |
0.331 |
|
| 2016 |
Lanctôt KL, Boot BP, Bain LJ, Hendrix JA, Carrillo MC. Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 1031-2. PMID 27600953 DOI: 10.1016/J.Jalz.2016.08.002 |
0.324 |
|
| 2016 |
Rosenberg PB, Lanctôt KL, Herrmann N, Mintzer JE, Porsteinsson AP, Sun X, Raman R. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27567808 DOI: 10.3233/Jad-151113 |
0.368 |
|
| 2016 |
Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A, Lanctôt KL. Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Psychopharmacology. PMID 27529771 DOI: 10.1097/Jcp.0000000000000565 |
0.36 |
|
| 2016 |
Lanctôt KL, Agüera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, Marshall GA, Mortby ME, Onyike CU, Padala PR, Politis AM, Rosenberg PB, Siegel E, Sultzer DL, Abraham EH. Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27362291 DOI: 10.1016/J.Jalz.2016.05.008 |
0.348 |
|
| 2016 |
Liu CS, Adibfar A, Herrmann N, Gallagher D, Lanctôt KL. Evidence for Inflammation-Associated Depression. Current Topics in Behavioral Neurosciences. PMID 27221622 DOI: 10.1007/7854_2016_2 |
0.304 |
|
| 2016 |
Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL. Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments. Current Alzheimer Research. PMID 27137221 DOI: 10.2174/1567205013666160502122933 |
0.321 |
|
| 2016 |
Swartz RH, Bayley M, Lanctôt KL, Murray BJ, Cayley ML, Lien K, Sicard MN, Thorpe KE, Dowlatshahi D, Mandzia JL, Casaubon LK, Saposnik G, Perez Y, Sahlas DJ, Herrmann N. Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screening. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27073189 DOI: 10.1177/1747493016641968 |
0.301 |
|
| 2016 |
Hawkins M, Schaffer A, Reis C, Sinyor M, Herrmann N, Lanctôt KL. Suicide in males and females with cardiovascular disease and comorbid depression. Journal of Affective Disorders. 197: 88-93. PMID 26971126 DOI: 10.1016/J.Jad.2016.02.061 |
0.3 |
|
| 2016 |
Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Smith EE, Sahlas DJ, Herrmann N, Cohen A, Thorpe KE. Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment. Stroke; a Journal of Cerebral Circulation. 47: 807-813. PMID 26903584 DOI: 10.1161/Strokeaha.115.011036 |
0.326 |
|
| 2016 |
Chau SA, Chung J, Herrmann N, Eizenman M, Lanctôt KL. Apathy and Attentional Biases in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26890774 DOI: 10.3233/Jad-151026 |
0.381 |
|
| 2016 |
Adibfar A, Saleem M, Lanctot KL, Herrmann N. Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review. Current Molecular Medicine. 16: 137-64. PMID 26812919 DOI: 10.2174/1566524016666160126144143 |
0.35 |
|
| 2016 |
Mazereeuw G, Herrmann N, Ma DW, Hillyer LM, Oh PI, Lanctôt KL. Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients. Brain, Behavior, and Immunity. 53: 54-8. PMID 26697998 DOI: 10.1016/J.Bbi.2015.12.009 |
0.331 |
|
| 2016 |
Dinoff A, Herrmann N, Saleem M, Oh PI, Lanctot KL. P1-190: The Association Between Endothelial Dysfunction and Memory Performance in Patients With Coronary Artery Disease Undertaking Cardiac Rehabilitation Alzheimer's & Dementia. 12: P476-P477. DOI: 10.1016/J.Jalz.2016.06.938 |
0.306 |
|
| 2016 |
Herrmann N, Mazereeuw G, Oh PI, Ma DW, Kiss A, Lanctôt KL. P4-158: Omega-3 Fatty Acids and Cognitive Performance in Coronary Artery Disease Patients: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial Alzheimer's & Dementia. 12: P1075-P1075. DOI: 10.1016/J.Jalz.2016.06.2250 |
0.335 |
|
| 2016 |
Adibfar A, Herrmann N, Mazereeuw G, Andreazza AC, Oh PI, Lanctot KL. Evaluating The Relationship Between Markers Of Oxidative Stress And Cognitive Performance In Coronary Artery Disease Patients Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1841 |
0.324 |
|
| 2016 |
Swardfager W, Cogo-Moreira H, Herrmann N, Masellis M, Ramirez J, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Sahlas DJ, Kiss A, Oh PI, Strother SC, Gao F, et al. P2-260: WHITE MATTER HYPERINTENSITIES AND VERBAL MEMORY: AN INDIRECT RELATIONSHIP MEDIATED BY TEMPORAL LOBE ATROPHY Alzheimer's & Dementia. 12: P726-P727. DOI: 10.1016/J.Jalz.2016.06.1429 |
0.523 |
|
| 2016 |
Saleem M, Herrmann N, Dinoff A, Mazereeuw G, Oh PI, Goldstein B, Lanctot KL. P1-371: The Association Between Apathy and Executive Function in Coronary Artery Disease Patients is Modified By Endothelial Dysfunction Alzheimer's & Dementia. 12: P573-P574. DOI: 10.1016/J.Jalz.2016.06.1123 |
0.308 |
|
| 2016 |
Kirkham JG, Takwoingi Y, Quinn TJ, Rapoport M, Lanctôt KL, Maxwell CJ, Herrmann N, Gill SS, Rochon PA, Seitz DP. Depression rating scales for detection of major depression in people with dementia Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.Cd012312 |
0.336 |
|
| 2015 |
Chau SA, Herrmann N, Eizenman M, Chung J, Lanctôt KL. Exploring Visual Selective Attention towards Novel Stimuli in Alzheimer's Disease Patients. Dementia and Geriatric Cognitive Disorders Extra. 5: 492-502. PMID 26955382 DOI: 10.1159/000442383 |
0.338 |
|
| 2015 |
O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N. Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials. The Journal of Clinical Psychiatry. 76: e1424-31. PMID 26646039 DOI: 10.4088/Jcp.14R09237 |
0.348 |
|
| 2015 |
Gallagher D, Kiss A, Lanctot K, Herrmann N. Depressive symptoms and cognitive decline: A longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. Journal of Affective Disorders. 190: 235-240. PMID 26521086 DOI: 10.1016/J.Jad.2015.09.046 |
0.358 |
|
| 2015 |
Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL. A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease. Journal of the American Medical Directors Association. PMID 26482056 DOI: 10.1016/J.Jamda.2015.08.019 |
0.343 |
|
| 2015 |
Saleem M, Herrmann N, Swardfager W, Eisen R, Lanctôt KL. Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis. Journal of Alzheimer's Disease : Jad. 47: 669-79. PMID 26401702 DOI: 10.3233/Jad-150042 |
0.593 |
|
| 2015 |
Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SA, Lanctôt KL. Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study. Neuropsychiatric Disease and Treatment. 11: 2309-14. PMID 26379437 DOI: 10.2147/Ndt.S87111 |
0.334 |
|
| 2015 |
Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N. Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease. Cns Drugs. 29: 615-23. PMID 26271310 DOI: 10.1007/S40263-015-0270-Y |
0.343 |
|
| 2015 |
Swardfager W, Yang P, Herrmann N, Lanctôt KL, Shah BR, Kiss A, Oh PI. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes. Diabetic Medicine : a Journal of the British Diabetic Association. PMID 26220364 DOI: 10.1111/Dme.12872 |
0.581 |
|
| 2015 |
Herrmann N, Harimoto T, Balshaw R, Lanctôt KL. Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID). Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 189-99. PMID 26174219 DOI: 10.1177/070674371506000406 |
0.355 |
|
| 2015 |
Chau S, Herrmann N, Ruthirakuhan MT, Chen JJ, Lanctôt KL. Latrepirdine for Alzheimer's disease. The Cochrane Database of Systematic Reviews. 4: CD009524. PMID 25897825 DOI: 10.1002/14651858.Cd009524.Pub2 |
0.375 |
|
| 2015 |
Lai KS, Herrmann N, Saleem M, Lanctôt KL. Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review. Cardiovascular Psychiatry and Neurology. 2015: 209569. PMID 25785192 DOI: 10.1155/2015/209569 |
0.332 |
|
| 2015 |
Santiago C, Herrmann N, Swardfager W, Saleem M, Oh PI, Black SE, Lanctôt KL. White Matter Microstructural Integrity Is Associated with Executive Function and Processing Speed in Older Adults with Coronary Artery Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 23: 754-63. PMID 25499674 DOI: 10.1016/J.Jagp.2014.09.008 |
0.586 |
|
| 2015 |
MacIntosh BJ, Swardfager W, Robertson AD, Tchistiakova E, Saleem M, Oh PI, Herrmann N, Stefanovic B, Lanctôt KL. Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease. Ajnr. American Journal of Neuroradiology. 36: 295-301. PMID 25147198 DOI: 10.3174/Ajnr.A4094 |
0.522 |
|
| 2015 |
Swardfager W, Herrmann N, Mazereeuw G, Lanctôt KL. Reply to: Serum zinc and the risk of depression in men: observations from a 20-year follow-up study. Biological Psychiatry. 77: e13-4. PMID 25034951 DOI: 10.1016/J.Biopsych.2014.06.006 |
0.549 |
|
| 2015 |
Agüera-Ortiz L, Gil-Ruiz N, Cruz-Orduña I, Ramos-García I, Osorio RS, Valentí-Soler M, Olazarán-Rodriguez J, Dobato-Ayuso JL, Lanctôt K, Martínez-Martín P. A Novel Rating Scale for the Measurement of Apathy in Institutionalized Persons with Dementia: The APADEM-NH American Journal of Geriatric Psychiatry. 23: 149-159. PMID 23871117 DOI: 10.1016/J.Jagp.2013.01.079 |
0.34 |
|
| 2015 |
Lanctôt K, Ruthirakuhan M, O'Regan J, Eryavec G, Williams E, Kiss A, Black SE, Herrmann N. P2-095: Predictors of worsening following cholinesterase inhibitor discontinuation trial in institutionalized persons with moderate to severe Alzheimer's disease: Results of a double-blind, placebo controlled trial Alzheimer's & Dementia. 11: P520-P520. DOI: 10.1016/J.Jalz.2015.06.632 |
0.312 |
|
| 2014 |
Behl P, Edwards JD, Kiss A, Lanctot KL, Streiner DL, Black SE, Stuss DT. Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study. Alzheimer's Research & Therapy. 6: 48. PMID 25484926 DOI: 10.1186/Alzrt280 |
0.373 |
|
| 2014 |
Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL. Kynurenine and depressive symptoms in a poststroke population. Neuropsychiatric Disease and Treatment. 10: 1827-35. PMID 25285006 DOI: 10.2147/Ndt.S65740 |
0.497 |
|
| 2014 |
Swardfager W, Herrmann N, Andreazza AC, Swartz RH, Khan MM, Black SE, Lanctôt KL. Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress. Biomed Research International. 2014: 245210. PMID 25054133 DOI: 10.1155/2014/245210 |
0.565 |
|
| 2014 |
Mazereeuw G, Herrmann N, Xu H, Figeys D, Oh PI, Bennett SA, Lanctôt KL. Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. Journal of Neuroinflammation. 11: 119. PMID 24996486 DOI: 10.1186/1742-2094-11-119 |
0.388 |
|
| 2014 |
MacIntosh BJ, Swardfager W, Crane DE, Ranepura N, Saleem M, Oh PI, Stefanovic B, Herrmann N, Lanctôt KL. Cardiopulmonary fitness correlates with regional cerebral grey matter perfusion and density in men with coronary artery disease. Plos One. 9: e91251. PMID 24622163 DOI: 10.1371/Journal.Pone.0091251 |
0.514 |
|
| 2014 |
Lanctôt KL, O'Regan J, Schwartz Y, Swardfager W, Saleem M, Oh PI, Herrmann N. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease. Psychosomatics. 55: 61-8. PMID 23993643 DOI: 10.1016/J.Psym.2013.04.004 |
0.601 |
|
| 2014 |
Lanctôt K. Challenges in the pharmacotherapy of apathy in Alzheimer's disease Neurobiology of Aging. 35: S13. DOI: 10.1016/J.Neurobiolaging.2014.01.081 |
0.333 |
|
| 2014 |
Swardfager W, Herrmann N, Shah BR, Yang P, Oh PI, Lanctôt KL. Depressive Symptoms Predict Non-Adherence to Exercise-Based Rehabilitation in Participants with Type 2 Diabetes Mellitus Canadian Journal of Diabetes. 38: S64. DOI: 10.1016/J.Jcjd.2014.07.180 |
0.558 |
|
| 2014 |
Lanctôt KL, Mazereeuw G, Herrmann N, Bennett SA, Xu H, Oh P. The Platelet Activating Factor PC(O-18:3/2:0) is Associated with Apathy Independently of Depressive Symptoms in Depressed Patients with Coronary Artery Disease The American Journal of Geriatric Psychiatry. 22: S110. DOI: 10.1016/J.Jagp.2013.12.127 |
0.329 |
|
| 2013 |
Herrmann N, Lanctôt KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer's Research & Therapy. 5: S5. PMID 24565367 DOI: 10.1186/Alzrt201 |
0.321 |
|
| 2013 |
Benhabib H, Lanctôt KL, Eryavec GM, Li A, Herrmann N. Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer's Disease. Canadian Geriatrics Journal : Cgj. 16: 180-5. PMID 24278094 DOI: 10.5770/Cgj.16.78 |
0.316 |
|
| 2013 |
Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE, ADMET Investigators. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. The Journal of Clinical Psychiatry. 74: 810-6. PMID 24021498 DOI: 10.4088/Jcp.12M08099 |
0.329 |
|
| 2013 |
Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biological Psychiatry. 74: 872-8. PMID 23806573 DOI: 10.1016/J.Biopsych.2013.05.008 |
0.552 |
|
| 2013 |
Feinstein A, Lapshin H, O'Connor P, Lanctôt KL. Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve. Journal of Neurology. 260: 2256-61. PMID 23736972 DOI: 10.1007/S00415-013-6952-9 |
0.325 |
|
| 2013 |
Lapshin H, Lanctôt KL, O'Connor P, Feinstein A. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1905-12. PMID 23652217 DOI: 10.1177/1352458513488841 |
0.302 |
|
| 2013 |
Swardfager W, Herrmann N, McIntyre RS, Mazereeuw G, Goldberger K, Cha DS, Schwartz Y, Lanctôt KL. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience and Biobehavioral Reviews. 37: 911-29. PMID 23567517 DOI: 10.1016/J.Neubiorev.2013.03.018 |
0.564 |
|
| 2013 |
Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE. Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 549-59. PMID 23567407 DOI: 10.1016/J.Jagp.2012.12.018 |
0.316 |
|
| 2013 |
Saleem M, Herrmann N, Swardfager W, Oh PI, Shammi P, Koren G, Van Uum S, Kiss A, Lanctôt KL. Higher cortisol predicts less improvement in verbal memory performance after cardiac rehabilitation in patients with coronary artery disease. Cardiovascular Psychiatry and Neurology. 2013: 340342. PMID 23401745 DOI: 10.1155/2013/340342 |
0.559 |
|
| 2013 |
Swardfager W, Winer DA, Herrmann N, Winer S, Lanctôt KL. Interleukin-17 in post-stroke neurodegeneration. Neuroscience and Biobehavioral Reviews. 37: 436-47. PMID 23370232 DOI: 10.1016/J.Neubiorev.2013.01.021 |
0.523 |
|
| 2013 |
Herrmann N, O'Regan J, Schwartz YB, Saleem M, Swardfager W, Lanctôt K. Cognitive Effects of Anticholinergic Medications in Patients with Coronary Artery Disease The American Journal of Geriatric Psychiatry. 21: S159. DOI: 10.1016/J.Jagp.2012.12.210 |
0.569 |
|
| 2012 |
Lapshin H, O'Connor P, Lanctôt KL, Feinstein A. Computerized cognitive testing for patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 1: 196-201. PMID 25877267 DOI: 10.1016/J.Msard.2012.05.001 |
0.31 |
|
| 2012 |
Swardfager W, Herrmann N, Cornish S, Mazereeuw G, Marzolini S, Sham L, Lanctôt KL. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. American Heart Journal. 163: 666-76.e1-3. PMID 22520533 DOI: 10.1016/J.Ahj.2011.12.017 |
0.557 |
|
| 2012 |
Mazereeuw G, Lanctôt KL, Chau SA, Swardfager W, Herrmann N. Effects of ω-3 fatty acids on cognitive performance: a meta-analysis. Neurobiology of Aging. 33: 1482.e17-29. PMID 22305186 DOI: 10.1016/J.Neurobiolaging.2011.12.014 |
0.606 |
|
| 2012 |
Lanctot K, Saleem M, Ratnam Bandaru VV, Herrmann N, Swardfager W, Mielke M, Haughey N, Oh P. P2-040: Plasma ceramide concentrations are associated with change in verbal memory performance in patients undertaking cardiac rehabilitation Alzheimer's & Dementia. 8: P277-P277. DOI: 10.1016/J.Jalz.2012.05.743 |
0.556 |
|
| 2012 |
Lanctot K, Mintzer J, Rosenberg P, Drye L, Scherer R, Herrmann N. P3-377: Apathy in dementia methylphenidate trial (ADMET): Recruiting for apathy in Alzheimer's disease Alzheimer's & Dementia. 8: P588-P588. DOI: 10.1016/J.Jalz.2012.05.1602 |
0.327 |
|
| 2012 |
Rosenberg P, Lanctot K, Drye L, Scherer R, Herrmann N, Mintzer J. P2-358: Safety profile of methylphenidate in apathetic patients with Alzheimer's disease: Apathy in Dementia Methylphenidate Trial (ADMET) Alzheimer's & Dementia. 8: P386-P386. DOI: 10.1016/J.Jalz.2012.05.1068 |
0.349 |
|
| 2011 |
Herrmann N, Chau SA, Kircanski I, Lanctôt KL. Current and emerging drug treatment options for Alzheimer's disease: a systematic review. Drugs. 71: 2031-65. PMID 21985169 DOI: 10.2165/11595870-000000000-00000 |
0.365 |
|
| 2011 |
Swardfager W, Herrmann N, Marzolini S, Oh PI, Saleem M, Shammi P, Kiss A, Cappell J, Lanctôt KL. Verbal memory performance and completion of cardiac rehabilitation in patients with coronary artery disease. Psychosomatic Medicine. 73: 580-7. PMID 21807866 DOI: 10.1097/Psy.0B013E318227Fff9 |
0.566 |
|
| 2011 |
Swardfager W, Herrmann N, Marzolini S, Saleem M, Shammi P, Oh PI, Albert PR, Daigle M, Kiss A, Lanctôt KL. Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease. Brain Behavior and Immunity. 25: 1264-1271. PMID 21554945 DOI: 10.1016/J.Bbi.2011.04.017 |
0.586 |
|
| 2011 |
Herrmann N, Cappell J, Eryavec GM, Lanctôt KL. Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study. Cns Drugs. 25: 425-33. PMID 21476613 DOI: 10.2165/11588160-000000000-00000 |
0.322 |
|
| 2011 |
Smart KA, Herrmann N, Lanctôt KL. Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research. Journal of Geriatric Psychiatry and Neurology. 24: 67-72. PMID 21460341 DOI: 10.1177/0891988711402347 |
0.336 |
|
| 2011 |
Herrmann N, Li A, Lanctôt K. Memantine in dementia: a review of the current evidence. Expert Opinion On Pharmacotherapy. 12: 787-800. PMID 21385152 DOI: 10.1517/14656566.2011.558006 |
0.324 |
|
| 2011 |
Pinto T, Lanctôt KL, Herrmann N. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type. Ageing Research Reviews. 10: 404-12. PMID 21292041 DOI: 10.1016/J.Arr.2011.01.003 |
0.343 |
|
| 2011 |
Mitchell RA, Herrmann N, Lanctôt KL. The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. Cns Neuroscience & Therapeutics. 17: 411-27. PMID 20560994 DOI: 10.1111/J.1755-5949.2010.00161.X |
0.346 |
|
| 2011 |
Herrmann N, Lanctôt KL. Long-term use of cholinesterase inhibitors: till death do us part? Neurodegenerative Disease Management. 1: 7-9. DOI: 10.2217/Nmt.10.3 |
0.322 |
|
| 2011 |
Middleton L, Brooks D, Oh P, Lanctôt K, Turner G, MacIntosh B, Black S. P3-308: Cardiac Rehabilitation: Benefits to people with MCI and Alzheimer's disease Alzheimer's & Dementia. 7: S614-S615. DOI: 10.1016/J.Jalz.2011.05.1750 |
0.33 |
|
| 2011 |
Herrmann N, Chau S, Hussman JM, Lanctôt KL. Dimebon for Alzheimer's disease Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd009524 |
0.329 |
|
| 2010 |
Herrmann N, Tam DY, Balshaw R, Sambrook R, Lesnikova N, Lanctôt KL. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 768-75. PMID 21172097 DOI: 10.1177/070674371005501204 |
0.312 |
|
| 2010 |
Cappell J, Herrmann N, Cornish S, Lanctôt KL. The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease. Cns Drugs. 24: 909-27. PMID 20932064 DOI: 10.2165/11539530-000000000-00000 |
0.361 |
|
| 2010 |
Dowlati Y, Herrmann N, Swardfager W, Thomson S, Oh PI, Van Uum S, Koren G, Lanctôt KL. Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease. Neuropsychiatric Disease and Treatment. 6: 393-400. PMID 20856603 |
0.537 |
|
| 2010 |
Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry. 68: 930-41. PMID 20692646 DOI: 10.1016/J.Biopsych.2010.06.012 |
0.599 |
|
| 2010 |
Swardfager W, Herrmann N, Marzolini S, Saleem M, Kiss A, Shammi P, Oh PI, Lanctôt KL. Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease. Journal of the American Geriatrics Society. 58: 1519-25. PMID 20646102 DOI: 10.1111/J.1532-5415.2010.02966.X |
0.586 |
|
| 2010 |
Dowlati Y, Herrmann N, Swardfager WL, Reim EK, Lanctôt KL. Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 91-9. PMID 20181304 DOI: 10.1177/070674371005500205 |
0.59 |
|
| 2010 |
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biological Psychiatry. 67: 446-57. PMID 20015486 DOI: 10.1016/J.Biopsych.2009.09.033 |
0.56 |
|
| 2010 |
Dowlati Y, Herrmann N, Swardfager W, Thomson S, Oh PI, Uum SV, Koren G, Lanctôt KL. Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease. Neuropsychiatric Disease and Treatment. 6: 393-400. DOI: 10.2147/Ndt.S10353 |
0.585 |
|
| 2009 |
Lanctôt KL, Rajaram RD, Herrmann N. Therapy for Alzheimer's Disease: How Effective are Current Treatments? Therapeutic Advances in Neurological Disorders. 2: 163-80. PMID 21179526 DOI: 10.1177/1756285609102724 |
0.32 |
|
| 2009 |
Lanctôt KL, Hsiung GY, Feldman HH, Masoud ST, Sham L, Herrmann N. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease. International Journal of Geriatric Psychiatry. 24: 1174-6. PMID 19768698 DOI: 10.1002/Gps.2273 |
0.317 |
|
| 2009 |
Herrmann N, Rapoport MJ, Rajaram RD, Chan F, Kiss A, Ma AK, Feinstein A, McCullagh S, Lanctôt KL. Factor analysis of the rivermead post-concussion symptoms questionnaire in mild-to-moderate traumatic brain injury patients Journal of Neuropsychiatry and Clinical Neurosciences. 21: 181-188. PMID 19622689 DOI: 10.1176/Appi.Neuropsych.21.2.181 |
0.303 |
|
| 2009 |
Lanctôt KL, Herrmann N. Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 177-9. PMID 19595935 DOI: 10.1016/J.Jalz.2007.04.389 |
0.313 |
|
| 2009 |
Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctôt KL. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. Psychoneuroendocrinology. 34: 1560-6. PMID 19540675 DOI: 10.1016/J.Psyneuen.2009.05.019 |
0.584 |
|
| 2008 |
Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt KL. Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease. Journal of Rehabilitation Medicine. 40: 213-8. PMID 18292924 DOI: 10.2340/16501977-0151 |
0.585 |
|
| 2008 |
Rapoport MJ, Chan F, Lanctot K, Herrmann N, McCullagh S, Feinstein A. An open-label study of citalopram for major depression following traumatic brain injury. Journal of Psychopharmacology (Oxford, England). 22: 860-4. PMID 18208921 DOI: 10.1177/0269881107083845 |
0.305 |
|
| 2008 |
Herrmann N, Lanctôt KL. Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 630-46. PMID 18020111 DOI: 10.1177/070674370705201004 |
0.341 |
|
| 2007 |
Hogan DB, Bailey P, Carswell A, Clarke B, Cohen C, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Management of mild to moderate Alzheimer's disease and dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 355-84. PMID 19595958 DOI: 10.1016/J.Jalz.2007.07.006 |
0.337 |
|
| 2007 |
Thompson S, Herrmann N, Rapoport MJ, Lanctôt KL. Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 248-55. PMID 17500306 DOI: 10.1177/070674370705200407 |
0.361 |
|
| 2007 |
Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Archives of Neurology. 64: 266-72. PMID 17296844 DOI: 10.1001/Archneur.64.2.266 |
0.361 |
|
| 2007 |
Herrmann N, Lanctôt KL, Rothenburg LS, Eryavec G. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 23: 116-9. PMID 17148938 DOI: 10.1159/000097757 |
0.349 |
|
| 2007 |
Herrmann N, Lanctôt KL. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned? Drug Safety. 29: 833-43. PMID 16970508 DOI: 10.2165/00002018-200629100-00002 |
0.327 |
|
| 2007 |
Lanctôt KL, Herrmann N, Rothenburg L, Eryavec G. Behavioral correlates of GABAergic disruption in Alzheimer's disease. International Psychogeriatrics / Ipa. 19: 151-8. PMID 16870038 DOI: 10.1017/S1041610206003899 |
0.318 |
|
| 2007 |
Swardfager W, Oh P, Herrmann N, Lanctôt KL. COGNITIVE AND MOOD CORRELATES OF IMMUNE ACTIVATION IN PATIENTS ATTENDING CARDIAC REHABILITATION Journal of Cardiopulmonary Rehabilitation and Prevention. 27: 344. DOI: 10.1097/01.Hcr.0000291375.44762.87 |
0.506 |
|
| 2006 |
Mirza SS, Sapkota S, Ramirez J, Stuss DT, Herrmann N, Lanctot KL, Black SE, Masellis M. P4-286: NEUROPSYCHIATRIC SYMPTOMS PREDICT DAILY LIFE FUNCTIONALITY IN DEMENTIA PATIENTS: RESULTS FROM THE SUNNYBROOK DEMENTIA STUDY Alzheimer's & Dementia. 14: P1558-P1558. DOI: 10.1016/J.Jalz.2018.07.108 |
0.312 |
|
| 2006 |
Ruthirakuhan M, Herrmann N, Gallagher D, Verhoeff NPL, Black SE, Lanctot KL. P4-276: CEREBROCHOLESTEROL, A MARKER OF AGITATION SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1552-P1553. DOI: 10.1016/J.Jalz.2018.07.098 |
0.341 |
|
| 2006 |
Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPL, Gallagher D, Black SE, Lanctot KL. P3-250: INVESTIGATING BIOMARKERS OF AGITATION IN MODERATE-TO-SEVERE ALZHEIMER'S DISEASE PATIENTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL WITH NABILONE Alzheimer's & Dementia. 14: P1169-P1169. DOI: 10.1016/J.Jalz.2018.06.1609 |
0.339 |
|
| 2005 |
Herrmann N, Lanctôt KL. Do atypical antipsychotics cause stroke? Cns Drugs. 19: 91-103. PMID 15697324 DOI: 10.2165/00023210-200519020-00001 |
0.32 |
|
| 2005 |
Lanctôt KL, Herrmann N. Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease. Evidence-Based Mental Health. 8: 15. PMID 15671506 DOI: 10.1136/Ebmh.8.1.15 |
0.373 |
|
| 2005 |
Thompson S, Lanctôt KL, Herrmann N. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opinion On Drug Safety. 3: 425-40. PMID 15335298 DOI: 10.1517/14740338.3.5.425 |
0.353 |
|
| 2004 |
Herrmann N, Lanctôt KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia Journal of Neuropsychiatry and Clinical Neurosciences. 16: 261-276. PMID 15377733 DOI: 10.1176/Jnp.16.3.261 |
0.343 |
|
| 2004 |
Lanctôt KL, Herrmaan N, Mazzotta P, Khan LR, Ingber N. GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioral and psychological symptoms of dementia Canadian Journal of Psychiatry. 49: 439-453. PMID 15362248 DOI: 10.1177/070674370404900705 |
0.334 |
|
| 2004 |
Herrmann N, Lanctôt KL, Eryavec G, Van Reekum R, Khan LR. Growth hormone response to clonidine predicts aggression in Alzheimer's disease Psychoneuroendocrinology. 29: 1192-1197. PMID 15219643 DOI: 10.1016/J.Psyneuen.2004.02.001 |
0.331 |
|
| 2004 |
Lanctôt KL, Herrmann N, Einarson TR. Drug therapy for Alzheimer's disease Canadian Medical Association Journal. 170: 1372-1372. DOI: 10.1503/Cmaj.1040150 |
0.324 |
|
| 2002 |
Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 646-54. PMID 12377401 DOI: 10.1016/S0893-133X(02)00339-1 |
0.353 |
|
| 2002 |
Lanctôt KL, Herrmann N, van Reekum R, Eryavec G, Naranjo CA. Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease. International Journal of Geriatric Psychiatry. 17: 531-41. PMID 12112177 DOI: 10.1002/Gps.636 |
0.325 |
|
| 2002 |
Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Utility scores of symptom profiles in major depression. Psychiatry Research. 110: 189-97. PMID 12057830 DOI: 10.1016/S0165-1781(02)00097-5 |
0.301 |
|
| 2001 |
Rojas-Fernandez CH, Lanctôt KL, Allen DD, MacKnight C. Pharmacotherapy of behavioral and psychological symptoms of dementia: Time for a different paradigm? Pharmacotherapy. 21: 74-102. PMID 11191740 DOI: 10.1592/Phco.21.1.74.34437 |
0.322 |
|
| 2000 |
Lanctôt KL, Herrmann N. Donepezil for behavioural disorders associated with Lewy bodies: a case series. International Journal of Geriatric Psychiatry. 15: 338-45. PMID 10767734 DOI: 10.1002/(Sici)1099-1166(200004)15:4<338::Aid-Gps119>3.0.Co;2-U |
0.309 |
|
| 2000 |
Lanctot K, Oh P, Risebrough N, Mazzotta P. Pmt21: Deriving Health Utilities From Efficacy Outcome Scales In Alzheimer'S Disease (Ad) Value in Health. 3: 108. DOI: 10.1016/S1098-3015(11)70471-5 |
0.308 |
|
| 1999 |
LANCTOT K, HERRMANN N, ERYAVEC G, VANREEKUM R, NARANJO C. Gender variations in effect of sertraline on behavioral disorders (BD) in Alzheimer's disease (AD) Clinical Pharmacology & Therapeutics. 65: 190-190. DOI: 10.1016/S0009-9236(99)80293-8 |
0.311 |
|
| 1999 |
LANCTOT K, OH P, RISEBROUGH N, HERRMANN N. Cost-benefit analysis of cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD) Clinical Pharmacology & Therapeutics. 65: 169-169. DOI: 10.1016/S0009-9236(99)80209-4 |
0.318 |
|
| 1996 |
Herrmann N, Lanctôt KL, Naranjo CA. Behavioural Disorders in Demented Elderly Patients Cns Drugs. 6: 280-300. DOI: 10.2165/00023210-199606040-00004 |
0.32 |
|
| Show low-probability matches. |